Specialists

Progressive Pulmonary Fibrosis

Clinical Research Studies for Progressive Pulmonary Fibrosis (PPF)

Who’s eligible?

  • Patients 21 years and older
  • Patients* with a current diagnosis of interstitial lung disease (ILD) with signs or symptoms of progression in the last two years
  • At least one year of commitment with regular office visits. Optional extension of participation up to 3 years.
  • Patient compensation provided for time and participation

If you are eligible and enroll, you will receive all study-related care at no cost. You will also receive monitoring of your IPF by a research doctor.

*WWMG patients are welcome to apply. Patients seen outside of WWMG are accepted, however we will need medical records from your treating physician.

web button apply now to participate in a clinical research trial

For additional details or if you have questions, please call (425) 225-2780 or email clinicalresearch@wwmedgroup.com.